367 related articles for article (PubMed ID: 18758202)
21. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
Gallagher RM; Welz-Bosna M; Gammaitoni A
Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.
Koizumi W; Toma H; Watanabe K; Katayama K; Kawahara M; Matsui K; Takiuchi H; Yoshino K; Araki N; Kodama K; Kimura H; Kono I; Hasegawa H; Hatanaka K; Hiraga K; Takeda F
Jpn J Clin Oncol; 2004 Oct; 34(10):608-14. PubMed ID: 15591459
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of oxycodone for management of acute pain episodes in chronic neck pain patients.
Ma K; Jiang W; Zhou Q; Du DP
Int J Clin Pract; 2008 Feb; 62(2):241-7. PubMed ID: 18070045
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study.
Steigerwald I; Müller M; Davies A; Samper D; Sabatowski R; Baron R; Rozenberg S; Szczepanska-Szerej A; Gatti A; Kress HG
Curr Med Res Opin; 2012 Jun; 28(6):911-36. PubMed ID: 22443293
[TBL] [Abstract][Full Text] [Related]
25. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
Peniston JH; Gould E
Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of the sustained-release hydromorphone in neuropathic pain management: pooled analysis of three open-label studies.
Moulin DE; Richarz U; Wallace M; Jacobs A; Thipphawong J
J Pain Palliat Care Pharmacother; 2010 Sep; 24(3):200-12. PubMed ID: 20718640
[TBL] [Abstract][Full Text] [Related]
27. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study.
Gatti A; Sabato AF; Occhioni R; Colini Baldeschi G; Reale C
Eur Neurol; 2009; 61(3):129-37. PubMed ID: 19092248
[TBL] [Abstract][Full Text] [Related]
28. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
Lundorff L; Peuckmann V; Sjøgren P
Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379
[TBL] [Abstract][Full Text] [Related]
29. Opioid use by patients in an orthopedics spine clinic.
Mahowald ML; Singh JA; Majeski P
Arthritis Rheum; 2005 Jan; 52(1):312-21. PubMed ID: 15641058
[TBL] [Abstract][Full Text] [Related]
30. Use of oxycodone in polytrauma patients: the "Gemelli" experience.
Franceschi F; Marini M; Ursella S; Carbone L; Candelli M; Pignataro G; Gabrielli M; Santarelli L; Ojetti V; Giupponi B; Fiore V; Barbaro F; De Marco G; Buccelletti F; Mancini F; Roccarina D; Gigante G; Gasbarrini A; Gasbarrini G; Silveri NG
Eur Rev Med Pharmacol Sci; 2008; 12(2):123-6. PubMed ID: 18575163
[TBL] [Abstract][Full Text] [Related]
31. [Controlled release oxycodone--a new option in the treatment of severe and very severe pain].
Stiehl M
MMW Fortschr Med; 2004 Aug; 146(31-32):41. PubMed ID: 15529708
[No Abstract] [Full Text] [Related]
32. High dose controlled-release oxycodone in hospice care.
Bercovitch M; Adunsky A
J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy with flupirtine and opioid: open-label case series in the treatment of neuropathic pain associated with cancer.
Goodchild CS; Nelson J; Cooke I; Ashby M; Jackson K
Pain Med; 2008 Oct; 9(7):939-49. PubMed ID: 18950447
[TBL] [Abstract][Full Text] [Related]
34. [Clinical efficacy of oxycodone against cancer-related pain with a wide variety of pathophysiologies].
Sumitani M; Yamada Y
Gan To Kagaku Ryoho; 2011 Jun; 38(6):977-82. PubMed ID: 21677490
[TBL] [Abstract][Full Text] [Related]
35. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
36. Tapentadol prolonged release versus strong opioids for severe, chronic low back pain: results of an open-label, phase 3b study.
Gálvez R; Schäfer M; Hans G; Falke D; Steigerwald I
Adv Ther; 2013 Mar; 30(3):229-59. PubMed ID: 23475406
[TBL] [Abstract][Full Text] [Related]
37. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
[TBL] [Abstract][Full Text] [Related]
38. Oxycodone. Pharmacological profile and clinical data in chronic pain management.
Coluzzi F; Mattia C
Minerva Anestesiol; 2005; 71(7-8):451-60. PubMed ID: 16012419
[TBL] [Abstract][Full Text] [Related]
39. Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.
Yu SY;
Oncology; 2008; 74 Suppl 1():46-51. PubMed ID: 18758197
[TBL] [Abstract][Full Text] [Related]
40. Oxycodone vs. fentanyl in the treatment of early post-operative pain after laparoscopic cholecystectomy: a randomised double-blind study.
Koch S; Ahlburg P; Spangsberg N; Brock B; Tønnesen E; Nikolajsen L
Acta Anaesthesiol Scand; 2008 Jul; 52(6):845-50. PubMed ID: 18477082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]